Dpp3 inhibitor for myocardial protection and prevention of myocardial injury in critically ill patients with blood pressure decline
Assignee4TEEN4 Pharmaceuticals GmbH
InventorsAndreas Bergmann, Karine Bourgeois
Life of this patent
Estimating the term…
Abstract
Subject matter of the present invention is an inhibitor of the activity of DPP3 for use in therapy or intervention in a critically ill patient with a decline of blood pressure for myocardial protection and/or prevention of myocardial injury.
Claims53
1-16. (canceled)
A method for prevention of myocardial injury in a critically ill patient exhibiting a mean arterial pressure (MAP) of <65 mmHg, said method comprising the administration of an inhibitor of the activity of DPP3.
A method of treatment of myocardial injury in a critically ill patient exhibiting a mean arterial pressure (MAP) of <65 mmHg, said method comprising the administration of an inhibitor of the activity of DPP3.
Dependencies are inferred from the claim text.